Research Progress on Depression Fatigue

doi:10.12114/j.issn.1007-9572.2019.00.321

Abstract

Abstract: The relationship between fatigue and depression is very complex.As a symptom of depression，fatigue is a common premonitory symptom especially at the first attack of the depression.Fatigue is also a residual symptom of depression which is more prone to become chronic disease than other depressive symptoms and is highly related to patients' work and social function defects.Therefore，paying attention to fatigue of depressive patients has important significance for their clinical treatment，the improvement of their quality of life and the reduction of recurrence rate of depression.This article reviews the definition，clinical manifestation，adverse outcomes，mechanism，diagnosis and treatment of depression fatigue in order to provide a reference for doctors.

Key words: Fatigue, Depressive disorder, Signs and symptoms, Quality of life, Review

摘要： 疲劳感与抑郁症的关系十分复杂，其是抑郁症的一种常见症状；是一种普遍的抑郁症前驱症状，尤其是抑郁症首次发作时；也是抑郁症的一种残留症状，并且比其他抑郁症状更易趋于慢性化，与患者工作和社会功能缺损高度相关。因此，关注抑郁症患者的疲劳感症状对临床治疗抑郁症、改善患者的生活质量及降低复发率具有重要的临床意义。本文就抑郁症相关疲劳感的定义、临床表现、不良后果、产生机制、诊治进展进行综述，以期为广大医生提供参考。

关键词: 疲劳感, 抑郁症, 体征和症状, 生活质量, 综述

LI Miao,WANG Qunsong,JIA Hongxiao. Research Progress on Depression Fatigue　[J]. Chinese General Practice, 2019, 22(31): 3901-3904. DOI: 10.12114/j.issn.1007-9572.2019.00.321.
李苗,王群松,贾竑晓. 抑郁症相关疲劳感的研究进展[J]. 中国全科医学, 2019, 22(31): 3901-3904. DOI: 10.12114/j.issn.1007-9572.2019.00.321.

References

［1］World Health Organization. ICD-10精神与行为障碍分类［M］．范肖东，汪向东，于欣，等，译.北京：人民卫生出版社，1993：97-98.
［2］American Psychiatric Association.Diagnostic and statistical manual of mental disorders［M］．Washington DC：American Psychiatric Association，2013：163-164.
［3］SIU A L，US Preventive Services Task Force（USPSTF），BIBBINS-DOMINGO K，et al．Screening for depression in adults US Preventive Services Task Force recommendation statement［J］．JAMA，2016，315（4）：380-387．DOI：10.1001/jama.2015.18392.
［4］ADDINGTON A M，GALLO J J，FORD D E，et al．Epidemiology of unexplained fatigue and major depression in the community：the baltimore ECA follow-up，1981—1994［J］．Psychol Med，2001，31（6）：1037-1044．DOI：10.1017/s0033291701004214.
［5］ARNOLD L M．Understanding fatigue in major depressive disorder and other medical disorders［J］．Psychosomatics，2008，49（3）：185-190．DOI：10.1176/appi.psy.49.3.185.
［6］NYER M，MISCHOULON D，ALPERT J E，et al．College students with depressive symptoms with and without fatigue：differences in functioning，suicidality，anxiety，and depressive severity［J］．Ann Clin Psychiatry，2015，27（2）：100-108.
［7］TRIVEDI M H，RUSH A J，WISNIEWSKI S R，et al．Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D：implications for clinical practice［J］．Am J Psychiatry，2006，163（1）：28-40．DOI：10.1176/appi.ajp.163.1.28.
［8］GREENBERG P E，FOURNIER A A，SISITSKY T，et al．The economic burden of adults with major depressive disorder in the United States （2005 and 2010）［J］．J Clin Psychiatry，2015，76（2）：155-162．DOI：10.4088/JCP.14m09298.
［9］ROBINSON R L，STEPHENSON J J，DENNEHY E B，et al．The importance of unresolved fatigue in depression：costs and comorbidities［J］．Psychosomatics，2015，56（3）：274-285．DOI：10.1016/j.psym.2014.08.003.
［10］ROBINSON R L，GRABNER M，PALLI S R，et al．Covariates of depression and high utilizers of healthcare：impact on resource use and costs［J］．J Psychosom Res，2016，85：35-43．DOI：10.1016/j.jpsychores.2016.04.002.
［11］STAHL S M，ZHANG L，DAMATARCA C，et al．Brain circuits determine destiny in depression：a novel approach to the psychopharmacology of wakefulness，fatigue，and executive dysfunction in major depressive disorder［J］．J Clin Psychiatry，2003，64（suppl 14）：6-17．DOI：10.1007/S00357-003-0016-2.
［12］FAVA M，BALL S，NELSON J C，et al．Clinical relevance of fatigue as a residual symptom in major depressive disorder［J］．Depress Anxiety，2014，31（3）：250-257．DOI：10.1002/da.22199.
［13］ANISMAN H，MERALI Z，POULTER M O，et al．Cytokines as a precipitant of depressive illness：animal and human studies［J］．Curr Pharm Des，2005，11（8）：963-972．DOI：10.2174/1381612053381701．
［14］SIMON N M，MCNAMARA K，CHOW C W，et al．A detailed examination of cytokine abnormalities in major depressive disorder［J］．Eur Neuropsychopharmacol，2008，18（3）：230-233．DOI：10.1016/j.euroneuro.2007.06.004.
［15］MCCLINTOCK S M，HUSAIN M M，WISNIEWSKI S R，et al．Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication［J］．J Clin Psychopharmacol，2011，31（2）：180-186．DOI：10.1097/jcp.0b013e31820ebd2c.
［16］BALDWIN D S，PAPAKOSTAS G I．Symptoms of fatigue and sleepiness in major depressive disorder［J］．J Clin Psychiatry，2006，67：9-15．DOI：10.1080/13803390590929298.
［17］SCHWEITZER P K．Principles and practice of sleep medicine［M］．6th ed．Philadelphia：PA，2017：480-498.
［18］FERENTINOS P P，KONTAXAKIS V P，HAVAKI-KONTAXAKI B J，et al．The measurement of fatigue in depression［J］．Psychopathology，2007，40（2）：133-134．DOI：10.1159/000098494.
［19］MATZA L S，WYRWICH K W，PHILLIPS G A，et al．The fatigue associated with depression scale：responsiveness and responder definition［J］．Qual Life Res，2013，22（2）：351-360．DOI：10.1007/s11136-012-0142-6.
［20］COOPER J A，TUCKER V L．Resolution of sleepiness and fatigue：a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union［J］．J Psychopharmacol，2014，28（2）：118-124．DOI：10.1177/0269881113514878.
［21］DEBATTISTA C，DOGHRAMJI K，MENZA M A，et al．Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder：a preliminary doubleblind placebo-controlled study［J］．J Clin Psychiatry，2003，64（9）：1057-1064．DOI：10.1111/1469-7610.00176_12.
［22］FAVA M，THASE M E，DEBATTISTA C．A multicenter，placebocontrolled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness［J］．J Clin Psychiatry，2005，66（1）：85-93．DOI：10.0000/PMID15669893.

[1]	GAO Jing, ZHOU Shangcheng, GAO Sande, ZOU Guanyang, CHEN Yingyao. Health-related Quality of Life and Its Influencing Factors in Patients with Prevention of Disease in Traditionnal Chinese Medicine based on EQ-5D-5L Scale [J]. Chinese General Practice, 2023, 26(32): 4043-4050.
[2]	REN Yanfeng, LIU Shimeng, TAO Ying, CHEN Yingyao. A Systematic Review of Medication Preferences for Patients with Depression Based on Discrete Choice Experiment and Best-worst Scaling [J]. Chinese General Practice, 2023, 26(28): 3559-3564.
[3]	HU Jingyi, HONG Jing, GUO Xiaodong, ZHANG Xiaohong, MO Ning, ZHOU Xiaocui, YU Qin, ZHOU Minhua, SUN Yan, NI Liu, SHI Xiaoli, SU Xiaoqing, LI Yuqian. Efficacy of Community-involved Hospice Care for Patients with Advanced Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(28): 3573-3584.
[4]	LIANG Xuemei, WANG Rui, ZHAO Yuhuan, XU Tianjiao, WANG Wei, SUN Weidong. Transcranial Low-level Laser Therapy: a Novel Treatment for Depression [J]. Chinese General Practice, 2023, 26(27): 3335-3341.
[5]	XUE Shan, LI Laiyou, LIANG Junli, JIN Yinghui, WEI Shuyan. The Efficacy and Safety of Home Enteral Nutrition in Patients with Esophageal Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(20): 2540-2547.
[6]	ZHANG Xingshan, LIN Yue, WAN Chonghua, SONG Aifeng, PAN Haiyan. A Nephrotic Syndrome-specific Quality of Life Scale: Development Based on the Quality of Life Instruments for Chronic Diseases, and Verification Using the Classical Test Theory [J]. Chinese General Practice, 2023, 26(20): 2488-2495.
[7]	LI Peiwen, HE Jiahui, MA Ximin, QIAO Hui. Health-related Quality of Life Measured Using the EQ-5D-3L and Health Service Utilization in Rural Residents of Ningxia [J]. Chinese General Practice, 2023, 26(19): 2361-2368.
[8]	ZHA Qianqian, XU Lianying, CHEN Juan, HUANG Wen, ZHANG Xinqiong. Summary of Best Evidence for Prevention of Recurrence of Late-life Depression [J]. Chinese General Practice, 2023, 26(19): 2332-2338.
[9]	WU Xiaoyu, WAN Chonghua, CHEN Ying, RUAN Yanqin, WENG Yijie, XU Xiaojiang. A Review of Studies on Patient-reported Outcomes and Disease-specific Health-related Quality of Life Instruments for Irritable Bowel Syndrome [J]. Chinese General Practice, 2023, 26(18): 2268-2276.
[10]	ZHENG Qingyong, ZHAO Liang, WEI Wei, REN Xuejun, WANG Chao, SUN Rui, CONG Minghua, YU Lei, YANG Min. Mindfulness-based Stress Reduction Can Improve Psychological Condition in Breast Cancer Patients: an Overview of Systematic Reviews [J]. Chinese General Practice, 2023, 26(12): 1503-1512.
[11]	DONG Linrui, CHANG Qingqing, MA Jianjun, LIU Chuanze, GUO Dashuai, LI Xiaohuan, FAN Yongyan, LI Dongsheng. Correlation between Autonomic Dysfunction and Cognitive Impairment in Patients with Parkinson's Disease [J]. Chinese General Practice, 2023, 26(12): 1450-1455,1471.
[12]	DU Yeming, ZHANG Yunqiao, WANG Zongqi, MIN Xue, CUI Yalian, WANG Yanfang. Characteristics of Somatic Symptoms and Their Correlations with Brain-derived Neurotrophic Factor and Inflammatory Cytokinesin Patients with Major Depressive Disorder [J]. Chinese General Practice, 2023, 26(12): 1463-1471.
[13]	WU Jiahao, WANG Ju, YANG Wei, LIU Xiaoli, ZHANG Longju. Atypical Alveolar Proteinosis: a Case Report and Review of Literature [J]. Chinese General Practice, 2023, 26(11): 1411-1414.
[14]	ZHAO Zixiang, XIAO Jing, FENG Yan, JIANG Yue. Intimate Partner Violence: Clinical Outcomes, Recognition and Management Techniques [J]. Chinese General Practice, 2023, 26(10): 1278-1281,1286.
[15]	GUAN Ningxiao, YAO Zhuoya, LI Ye, LIU Ziwei, LIU Fangli. Non-invasive Brain Stimulation Techniques Can Effectively Relieve Post-stroke Fatigue: a Meta-analysis [J]. Chinese General Practice, 2023, 26(08): 1008-1014.